Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoproliferative Disorders × Pemetrexed × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 167 Lung Neoplasms 61 Neoplasms 21 Neoplasm Metastasis 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Mesothelioma, Malignant 12 Colorectal Neoplasms 10 Carcinoma 10 Meningeal Carcinomatosis 9 Mesothelioma 6 Melanoma 6 Brain Neoplasms 6 NSCLC 5 Adenocarcinoma of Lung 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Neoplasms by Site 4 Lung Diseases 4 Carcinoma, Bronchogenic 4 Advanced Solid Tumors 4 Thoracic Neoplasms 3 Small Cell Lung Carcinoma 3 Respiratory Tract Neoplasms 3 Rectal Neoplasms 3 Neoplasms by Histologic Type 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Bronchial Neoplasms 3

Interventions

Cyclophosphamide 6 fludarabine 4 Rituximab 4 fludarabine phosphate 3 Vincristine 3 Tacrolimus 3 Prednisone 3 Mycophenolic Acid 3 Etoposide 3 Doxorubicin 3 Busulfan 3 venetoclax 2 Whole-Body Irradiation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mesna 2 Melphalan 2 Bortezomib 2 trametinib 1 pertuzumab 1 liposomal doxorubicin 1 isatuximab 1 ibrutinib 1 etoposide phosphate 1 enzalutamide 1 entrectinib 1 dabrafenib 1 cobimetinib 1 capmatinib 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡